Tag : Qurient

Latest News

Qurient Announces Publication in New England Journal of Medicine of Phase 2 Data for Telacebec, a First-in-Class Antibiotic for the Treatment of Tuberculosis

SEONGNAM-SI, Korea–(BUSINESS WIRE)– #Antibiotic–Qurient announced the publication in NEJM of positive results from the Phase 2 clinical trial for telacebec for the treatment of tuberculosis...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy